ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Total du passif68.61 M72.56 M71.08 M72.73 M69.14 M65.72 MTotal des capitaux propres134.02 M112.74 M94.16 M74.06 M62.3 M49.4 MTotal du passif et des capitaux propres202.63 M185.3 M165.23 M146.79 M131.44 M115.12 MDette totale——————Dette nette——————
Silence Therapeutics Plc - American Depository Share
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.